314 related articles for article (PubMed ID: 17768084)
21. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Gelderblom HC; Menting S; Beld MG
Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.
May S; Adamska E; Tang JW
J Clin Virol; 2018 Sep; 106():7-10. PubMed ID: 30007139
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
[TBL] [Abstract][Full Text] [Related]
25. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil.
Swanson P; Huang S; Holzmayer V; Bodelle P; Yamaguchi J; Brennan C; Badaro R; Brites C; Abravaya K; Devare SG; Hackett J
J Virol Methods; 2006 Jun; 134(1-2):237-43. PubMed ID: 16510195
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads, 2007].
; Orta Mira N; Guna Serrano Mdel R; Latorre Martínez JC; Ovies MR; Pérez JL; Gimeno Cardona C
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():8-13. PubMed ID: 19100161
[TBL] [Abstract][Full Text] [Related]
27. Standardization and performance evaluation of "modified" and "ultrasensitive" versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia.
Amendola A; Bloisi M; Marsella P; Sabatini R; Bibbò A; Angeletti C; Capobianchi MR
J Clin Virol; 2011 Sep; 52(1):17-22. PubMed ID: 21764631
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.
Foulongne V; Montes B; Didelot-Rousseau MN; Segondy M
J Clin Microbiol; 2006 Aug; 44(8):2963-6. PubMed ID: 16891517
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece.
Katsoulidou A; Rokka C; Issaris C; Haida C; Tzannis K; Sypsa V; Detsika M; Paraskevis D; Hatzakis A
Virol J; 2011 Jan; 8():10. PubMed ID: 21219667
[TBL] [Abstract][Full Text] [Related]
30. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
31. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
[TBL] [Abstract][Full Text] [Related]
32. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.
Paba P; Fabeni L; Ciccozzi M; Perno CF; Ciotti M
J Virol Methods; 2011 May; 173(2):399-402. PubMed ID: 21419171
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples.
Mouna L; Pallier C; Proust S; Prégermain C; Roque-Afonso AM
J Clin Virol; 2020 May; 126():104331. PubMed ID: 32179444
[TBL] [Abstract][Full Text] [Related]
35. Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples.
Adami V; Falasca E; Dorotea L; Malangone W; Astori G; Marini L; Biffoni F; Rinaldi C; Degrassi A; Pipan C
Clin Microbiol Infect; 2004 Dec; 10(12):1075-80. PubMed ID: 15606634
[TBL] [Abstract][Full Text] [Related]
36. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
[TBL] [Abstract][Full Text] [Related]
37. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
38. Performance evaluation of the Aptima
Garbuglia AR; Bibbò A; Sciamanna R; Pisciotta M; Capobianchi MR
J Clin Virol; 2017 Jul; 92():1-6. PubMed ID: 28475925
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
40. Experience with PCR screening.
Sun R; Jayakar H; Yeh S; Mendoza M; Wisbeski MH; Iszczyszyn W; Dragon EA
Dev Biol (Basel); 2000; 102():81-91. PubMed ID: 10794093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
